This evidence has conferred a neuroprotective role of TGF-β in Alzheimer’s disease; therefore, re-establishing the alteration of TGF-β1 signaling could be an alternative in the treatment for this and other neurodegenerative diseases [47]. The gene discussed is TGFB1; the disease is neurodegenerative disease.